Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Sorafenib
Related studies linked through entity extraction aliases.
Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Trial of Transcatheter Arterial Chemoembolization (TACE) With Sorafenib for Locally Advanced Hepatocellular Carcinoma (HCC)
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
Proton Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With HCC Exceeding San Francisco Criteria
- Status
- TERMINATED
- Phase
- NA
Sorafenib Plus S-1 in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib for Imatinib/Sunitinib-failed GIST
- Status
- COMPLETED
- Phase
- PHASE2
An Expanded Cohort Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
An Extension Treatment Protocol for Subjects Who Have Participated in a Study of Tivozanib Versus Sorafenib in Kidney Carcinoma (Protocol AV-951-09-301).
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
- Status
- TERMINATED
- Phase
- PHASE3
Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- NA
Phase I/II Comparison of Efficacy and Safety of BIBF 1120 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I / II Trial of Nintedanib in Asian Hepatocellular Carcinoma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
- Status
- COMPLETED
- Phase
- PHASE1